Vatera Healthcare Partners

Description

• Vatera Healthcare Partners is the dedicated venture capital and private equity investing arm of Vatera Holdings LLC, a New York City-based family office advisor. Vatera Healthcare Partners invests in biopharmaceutical companies with the goal of developing best-in-class therapies to treat unmet medical needs and improve patients lives. The firm aims to build companies by leveraging its teams collective experience, expertise and strong network of relationships in the industry and academia. Vatera Healthcare Partners makes selective investments with a long-term, patient approach that enables strong alignment with therapeutic development cycles. The firm makes both controlling and minority investments and is actively involved with its portfolio companies and their management teams. Vatera Healthcare Partners successes include the recent sale of Pearl Therapeutics Inc., which develops combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease and asthma, to AstraZeneca for up to $1.15 billion. Currently, Vatera Healthcare Partners has a number of portfolio company investments, including early-stage clinical development companies, late-stage clinical development companies and revenue-generating private companies.
• 

  Headquarters:499 Park Ave Fl 23 , New York, New York, United States

  More
• 

  Phone Number: +1 212-588-1109

• 

  Website: https://www.vaterahealthcare.com

• 

  Employees:1

• 

  Revenue:$1 - 10M

• 

  Legal Name:Vatera Healthcare Partners

• Vatera Healthcare Partners's Social Media

  
• Is this data correct?

• |  NAICS Code: 551112  |

  Show More